Literature DB >> 17156813

Alphavirus replicon approach to promoterless analysis of IRES elements.

K I Kamrud1, M Custer, J M Dudek, G Owens, K D Alterson, J S Lee, J L Groebner, J F Smith.   

Abstract

Here we describe a system for promoterless analysis of putative internal ribosome entry site (IRES) elements using an alphavirus (family Togaviridae) replicon vector. The system uses the alphavirus subgenomic promoter to produce transcripts that, when modified to contain a spacer region upstream of an IRES element, allow analysis of cap-independent translation of genes of interest (GOI). If the IRES element is removed, translation of the subgenomic transcript can be reduced >95% compared to the same transcript containing a functional IRES element. Alphavirus replicons, used in this manner, offer an alternative to standard dicistronic DNA vectors or in vitro translation systems currently used to analyze putative IRES elements. In addition, protein expression levels varied depending on the spacer element located upstream of each IRES. The ability to modulate the level of expression from alphavirus vectors should extend the utility of these vectors in vaccine development.

Mesh:

Substances:

Year:  2006        PMID: 17156813      PMCID: PMC1885372          DOI: 10.1016/j.virol.2006.10.049

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  63 in total

1.  Identification and characterization of a novel cell cycle-regulated internal ribosome entry site.

Authors:  S Cornelis; Y Bruynooghe; G Denecker; S Van Huffel; S Tinton; R Beyaert
Journal:  Mol Cell       Date:  2000-04       Impact factor: 17.970

2.  Venezuelan equine encephalitis replicon immunization overcomes intrinsic tolerance and elicits effective anti-tumor immunity to the 'self' tumor-associated antigen, neu in a rat mammary tumor model.

Authors:  Edward L Nelson; Darue Prieto; Terri G Alexander; Peter Pushko; Loreen A Lofts; Jonathan O Rayner; Kurt I Kamrud; Bolyn Fralish; Jonathan F Smith
Journal:  Breast Cancer Res Treat       Date:  2003-12       Impact factor: 4.872

3.  Improvement of DNA vaccine immunogenicity by a dual antigen expression system.

Authors:  Shin Sasaki; Fumihiko Takeshita; Tomohiro Oikawa; Yoshitsugu Kojima; Ke-Qin Xin; Kenji Okuda; Norihisa Ishii
Journal:  Biochem Biophys Res Commun       Date:  2004-02-27       Impact factor: 3.575

4.  Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles.

Authors:  N L Davis; I J Caley; K W Brown; M R Betts; D M Irlbeck; K M McGrath; M J Connell; D C Montefiori; J A Frelinger; R Swanstrom; P R Johnson; R E Johnston
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene.

Authors:  J zur Megede; M C Chen; B Doe; M Schaefer; C E Greer; M Selby; G R Otten; S W Barnett
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

6.  Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis.

Authors:  G H MacDonald; R E Johnston
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  Functional characterization of the X-linked inhibitor of apoptosis (XIAP) internal ribosome entry site element: role of La autoantigen in XIAP translation.

Authors:  M Holcik; R G Korneluk
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

8.  Enterovirus 71 contains a type I IRES element that functions when eukaryotic initiation factor eIF4G is cleaved.

Authors:  Sunnie R Thompson; Peter Sarnow
Journal:  Virology       Date:  2003-10-10       Impact factor: 3.616

9.  Tight control of platelet-derived growth factor B/c-sis expression by interplay between the 5'-untranslated region sequence and the major upstream promoter.

Authors:  Baoguang Han; Zizheng Dong; Jian-Ting Zhang
Journal:  J Biol Chem       Date:  2003-09-05       Impact factor: 5.157

10.  Demonstrating internal ribosome entry sites in eukaryotic mRNAs using stringent RNA test procedures.

Authors:  Marc E Van Eden; Marshall P Byrd; Kyle W Sherrill; Richard E Lloyd
Journal:  RNA       Date:  2004-04       Impact factor: 4.942

View more
  25 in total

1.  In vitro and in vivo characterization of microRNA-targeted alphavirus replicon and helper RNAs.

Authors:  Kurt I Kamrud; V McNeil Coffield; Gary Owens; Christin Goodman; Kim Alterson; Max Custer; Michael A Murphy; Whitney Lewis; Sarah Timberlake; Elizabeth K Wansley; Peter Berglund; Jonathan Smith
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

2.  Development and preclinical evaluation of an alphavirus replicon vaccine for influenza.

Authors:  Bolyn Hubby; Todd Talarico; Maureen Maughan; Elizabeth A Reap; Peter Berglund; Kurt I Kamrud; Laura Copp; Whitney Lewis; Chad Cecil; Pamela Norberg; Jordan Wagner; Aubrey Watson; Sarah Negri; Bruce K Burnett; Andrew Graham; Jonathan F Smith; Jeffrey D Chulay
Journal:  Vaccine       Date:  2007-10-05       Impact factor: 3.641

3.  Effects of rapid antigen degradation and VEE glycoprotein specificity on immune responses induced by a VEE replicon vaccine.

Authors:  M E Fluet; A C Whitmore; D A Moshkoff; K Fu; Y Tang; M L Collier; A West; D T Moore; R Swanstrom; R E Johnston; N L Davis
Journal:  Virology       Date:  2007-09-27       Impact factor: 3.616

4.  Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus.

Authors:  Elizabeth A Reap; John Morris; Sergey A Dryga; Maureen Maughan; Todd Talarico; Robert E Esch; Sarah Negri; Bruce Burnett; Andrew Graham; Robert A Olmsted; Jeffrey D Chulay
Journal:  Vaccine       Date:  2007-08-30       Impact factor: 3.641

5.  Rapid development of an efficacious swine vaccine for novel H1N1.

Authors:  Ryan Vander Veen; Kurt Kamrud; Mark Mogler; Alan T Loynachan; Jerry McVicker; Peter Berglund; Gary Owens; Sarah Timberlake; Whitney Lewis; Jonathan Smith; D L Hank Harris
Journal:  PLoS Curr       Date:  2009-10-29

Review 6.  mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases.

Authors:  Giulietta Maruggi; Cuiling Zhang; Junwei Li; Jeffrey B Ulmer; Dong Yu
Journal:  Mol Ther       Date:  2019-02-07       Impact factor: 11.454

7.  Attenuation of rabies virus replication and virulence by picornavirus internal ribosome entry site elements.

Authors:  Adriane Marschalek; Stefan Finke; Martin Schwemmle; Daniel Mayer; Bernd Heimrich; Lothar Stitz; Karl-Klaus Conzelmann
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

8.  Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates.

Authors:  Jay W Hooper; Anthony M Ferro; Joseph W Golden; Peter Silvera; Jeanne Dudek; Kim Alterson; Max Custer; Bryan Rivers; John Morris; Gary Owens; Jonathan F Smith; Kurt I Kamrud
Journal:  Vaccine       Date:  2009-10-13       Impact factor: 3.641

9.  Development and characterization of promoterless helper RNAs for the production of alphavirus replicon particle.

Authors:  K I Kamrud; K Alterson; M Custer; J Dudek; C Goodman; G Owens; J F Smith
Journal:  J Gen Virol       Date:  2010-02-24       Impact factor: 3.891

10.  Double subgenomic alphaviruses expressing multiple fluorescent proteins using a Rhopalosiphum padi virus internal ribosome entry site element.

Authors:  Michael R Wiley; Lisa O Roberts; Zach N Adelman; Kevin M Myles
Journal:  PLoS One       Date:  2010-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.